JORDAN YOUNG: Open Payments
NPI 1508224775 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,257 in 194 payments from 33 companies in 2025. Trend: 2023 $1,741 · 2024 $3,252 · 2025 $4,257
Food & beverage: $4,158Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $436 |
| SK Life Science, Inc. | 12 | $383 |
| ARGENX US, INC. | 11 | $324 |
| UCB, Inc. | 13 | $311 |
| PFIZER INC. | 20 | $273 |
| Novartis Pharmaceuticals Corporation | 10 | $241 |
| Alexion Pharmaceuticals, Inc. | 7 | $198 |
| ACADIA Pharmaceuticals Inc | 7 | $183 |
| Neurelis, Inc. | 6 | $175 |
| Lilly USA, LLC | 11 | $170 |
Products named: NURTEC ODT, KESIMPTA, QULIPTA, Rystiggo, REXULTI, VYVGART HYTRULO, NUPLAZID, VALTOCO.
Industry payments across VA — which companies pay providers there.
